Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

585
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
585
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

482
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
482
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

154
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
154
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.6K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.6K
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

145
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A...
145
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

155
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
155

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large language models for automated and audience-tailored labeling of latent classes.

JAMIA open·2026
Same author

Preemptive optimization of a clinical antibody for broad neutralization of SARS-CoV-2 variants and robustness against viral escape.

Science advances·2025
Same author

Computationally restoring the potency of a clinical antibody against Omicron.

Nature·2024
Same author

An exploration of knowledge-organizing technologies to advance transdisciplinary back pain research.

JOR spine·2023
Same author

Theoretical Schemas to Guide Back Pain Consortium (BACPAC) Chronic Low Back Pain Clinical Research.

Pain medicine (Malden, Mass.)·2022
Same author

Moving the needle: Employing deep reinforcement learning to push the boundaries of coarse-grained vaccine models.

Frontiers in immunology·2022

Related Experiment Video

Updated: Apr 25, 2026

Modeling Biological Membranes with Circuit Boards and Measuring Electrical Signals in Axons: Student Laboratory Exercises
13:56

Modeling Biological Membranes with Circuit Boards and Measuring Electrical Signals in Axons: Student Laboratory Exercises

Published on: January 18, 2011

23.8K

Toward modular biological models: defining analog modules based on referent physiological mechanisms.

Brenden K Petersen, Glen E P Ropella, C Anthony Hunt1

  • 1Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA. a.hunt@ucsf.edu.

BMC Systems Biology
|August 16, 2014
PubMed
Summary

Biomedical models are now isolated, hindering reuse. We developed physiomimetic mechanism modules (PMMs) for modularity, enabling easier integration and reuse across diverse biological modeling applications.

More Related Videos

Finite Element Modelling of a Cellular Electric Microenvironment
08:23

Finite Element Modelling of a Cellular Electric Microenvironment

Published on: May 18, 2021

4.2K
Design, Surface Treatment, Cellular Plating, and Culturing of Modular Neuronal Networks Composed of Functionally Inter-connected Circuits
10:32

Design, Surface Treatment, Cellular Plating, and Culturing of Modular Neuronal Networks Composed of Functionally Inter-connected Circuits

Published on: April 15, 2015

8.1K

Related Experiment Videos

Last Updated: Apr 25, 2026

Modeling Biological Membranes with Circuit Boards and Measuring Electrical Signals in Axons: Student Laboratory Exercises
13:56

Modeling Biological Membranes with Circuit Boards and Measuring Electrical Signals in Axons: Student Laboratory Exercises

Published on: January 18, 2011

23.8K
Finite Element Modelling of a Cellular Electric Microenvironment
08:23

Finite Element Modelling of a Cellular Electric Microenvironment

Published on: May 18, 2021

4.2K
Design, Surface Treatment, Cellular Plating, and Culturing of Modular Neuronal Networks Composed of Functionally Inter-connected Circuits
10:32

Design, Surface Treatment, Cellular Plating, and Culturing of Modular Neuronal Networks Composed of Functionally Inter-connected Circuits

Published on: April 15, 2015

8.1K

Area of Science:

  • Biomedical modeling and simulation
  • Computational biology
  • Software engineering for science

Background:

  • Current biomedical models often exist in isolation, limiting their reusability and integration.
  • Lack of modularity in existing models complicates addressing diverse project requirements and integrating components.
  • The heterogeneity of biology necessitates modular models adaptable to various use cases and experimental platforms.

Purpose of the Study:

  • To present a general, scientific method for modularizing biological mechanisms into reusable software components called physiomimetic mechanism modules (PMMs).
  • To demonstrate the feasibility and utility of PMMs across multiple biomedical modeling use cases.
  • To facilitate model reuse and integration, thereby accelerating biomedical research.

Main Methods:

  • Developed PMMs utilizing parametric containers to partition and expose state information into physiologically meaningful groupings.
  • Modularized four pharmacodynamic response mechanisms from an in silico liver (ISL) model.
  • Created an in silico hepatocyte culture (ISHC) model using the same PMMs without refactoring.

Main Results:

  • Verified the modularization process by confirming identical drug clearance results before and after modularization.
  • The modularized ISL achieved validation targets from propranolol outflow profile data.
  • The ISHC achieved validation targets from propranolol intrinsic clearance data, demonstrating robustness to experimental variability.

Conclusions:

  • Demonstrated the feasibility and multi-use case utility of PMMs in biomedical modeling.
  • The developed pharmacodynamic response module is robust to model context changes and flexible in achieving validation targets.
  • Adopting PMMs is expected to enhance model reuse and integration, accelerating biomedical research progress.